MAYZENT
MAYZENT
Approved
DIN Number
02496429
Drug Class
Human
Market Date
Apr 24, 2020
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02496429
AIG Number0162037001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AE03 SIPONIMOD
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification90:04.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
SIPONIMODActive
Strength: 0.25 MG
Monograph: SIPONIMOD